BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29469234)

  • 1. Gastrointestinal: Improvement of refractory oral ulcer of Behçet's disease after eradication of Helicobacter pylori.
    Okano A; Ohana M
    J Gastroenterol Hepatol; 2018 Mar; 33(3):560. PubMed ID: 29469234
    [No Abstract]   [Full Text] [Related]  

  • 2. The anti-Helicobacter pylori antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behcet's syndrome.
    Yildirim B; Oztürk MA; Unal S
    Rheumatol Int; 2009 Feb; 29(4):477-8. PubMed ID: 18802701
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased seropositivity of Helicobacter pylori cytotoxin-associated gene-A in Behçet's disease.
    Apan TZ; Gürsel R; Dolgun A
    Clin Rheumatol; 2007 Jun; 26(6):885-9. PubMed ID: 17021670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G; Ben-Chetrit E
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline use for Behçet's disease. The result of a survey among rheumatologists in North America.
    Liang GC; Chang EM
    Adv Exp Med Biol; 2003; 528():591-4. PubMed ID: 12918771
    [No Abstract]   [Full Text] [Related]  

  • 6. Is Helicobacter pylori associated with Behçet's syndrome? A meta-analysis.
    Yu Y; Yao X; Liang J; Lu C; Yan T; Lin J
    Helicobacter; 2019 Dec; 24(6):e12663. PubMed ID: 31617289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculitis and oral and genital ulcers: Behçet's syndrome or HIV infection?
    Olivé A; Fuente MJ; Veny A; Romeu J
    Clin Exp Rheumatol; 1999; 17(1):124. PubMed ID: 10084048
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab.
    Robertson LP; Hickling P
    Rheumatology (Oxford); 2001 Apr; 40(4):473-4. PubMed ID: 11312390
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
    Grayson PC; Yazici Y; Merideth M; Sen HN; Davis M; Novakovich E; Joyal E; Goldbach-Mansky R; Sibley CH
    Arthritis Res Ther; 2017 Mar; 19(1):69. PubMed ID: 28335798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
    Connolly M; Armstrong JS; Buckley DA
    Br J Dermatol; 2005 Nov; 153(5):1073-5. PubMed ID: 16225632
    [No Abstract]   [Full Text] [Related]  

  • 11. Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behçet's disease.
    Lopalco G; Fabiani C; Venerito V; Lapadula G; Iannone F; Cantarini L
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):130-131. PubMed ID: 28980903
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of colchicine in Helicobacter pylori prevalence and gastric mucosal changes in Behçet's Disease.
    Pata C; Konica K; Yazar A
    J Rheumatol; 2001 Sep; 28(9):2144. PubMed ID: 11824425
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of colchicine in Helicobacter pylori prevalence and gastric mucosal changes in Behçet's disease.
    Pata C; Konca K; Yazar A
    J Rheumatol; 2001 Aug; 28(8):1938. PubMed ID: 11508610
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of pemphigus vulgaris with folliculitis-like nodules, genital and oral ulcers difficult to differentiate from Behçet's disease.
    Yamaoka T; Takahashi S; Ijuin K; Nagai H; Kumagai S
    Clin Exp Rheumatol; 2023 Oct; 41(10):2128. PubMed ID: 37199175
    [No Abstract]   [Full Text] [Related]  

  • 15. Conjunctival ulcers in Behçet's disease.
    Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal Behçet's disease with Raynaud phenomenon.
    Fernández-Fructuoso JR; Gil-Sánchez S; Gómez-Santos E; Lloreda-García JM; Sevilla-Denia S; Leante-Castellanos JL
    J Neonatal Perinatal Med; 2016; 9(4):423-425. PubMed ID: 27834783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behçet's disease].
    Brand HS; van Beusichem FF; van Nieuw Amerongen A
    Ned Tijdschr Tandheelkd; 2008 Jun; 115(6):340-5. PubMed ID: 18618988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical cyclosporine-A for treatment of oral ulcers of Behçet's syndrome.
    Ergun T; Gürbüz O; Yurdakul S; Hamuryudan V; Bekiroğlu N; Yazici H
    Int J Dermatol; 1997 Sep; 36(9):720. PubMed ID: 9352422
    [No Abstract]   [Full Text] [Related]  

  • 19. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
    Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
    N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of Behçet's disease with lenalidomide.
    Green J; Upjohn E; McCormack C; Zeldis J; Prince HM
    Br J Dermatol; 2008 Jan; 158(1):197-8. PubMed ID: 17986298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.